Application of retinoic acid improves form and function of tissue engineered corneal construct.
Retinoic acid has recently been shown to control the phenotype and extracellular matrix composition of corneal stromal cells cultured in vitro as monolayers. This study set out to investigate the effects of retinoic acid on human corneal keratocytes within a 3D environment. Human corneal keratocytes were encapsulated in collagen gels, which were subsequently compressed under load, and cultured in serum-free media supplemented with 10 µM retinoic acid or DMSO vehicle for 30 days. Cell proliferation was quantified on selected days, while the expression of several important keratocytes markers was evaluated at day 30 using RT-PCR and immunoblotting. The weight and size of the collagen constructs were measured before and after hydration and contraction analyses. Retinoic acid enhanced keratocyte proliferation until day 30, whereas cells in control culture conditions showed reduced numbers after day 21. Both gene and protein expressions of keratocyte-characteristic proteoglycans (keratocan, lumican and decorin), corneal crystallins and collagen type I and V were significantly increased following retinoic acid supplementation. Retinoic acid also significantly reduced the expression of matrix metalloproteases 1, 3 and 9 while not increasing α-smooth muscle actin and fibronectin expression. Furthermore, these effects were also correlated with the ability of retinoic acid to significantly inhibit the contractility of keratocytes while allowing the build-up of corneal stromal extracellular matrix within the 3D constructs. Thus, retinoic acid supplementation represents a promising strategy to improve the phenotype of 3D-cultured keratocytes, and their usefulness as a model of corneal stroma for corneal biology and regenerative medicine applications.
a Institute of Genetic Medicine; Newcastle University; Center for Life ; Newcastle , UK.
Fadhilah Z
FZ
Abidin
a Institute of Genetic Medicine; Newcastle University; Center for Life ; Newcastle , UK.
Ricardo M
RM
Gouveia
a Institute of Genetic Medicine; Newcastle University; Center for Life ; Newcastle , UK.
Che J
CJ
Connon
D000328:Adult; D000368:Aged; D021522:Bioartificial Organs; D002478:Cells, Cultured; D003315:Cornea / Q000166:cytology / Q000187:drug effects / Q000254:growth & development*; D060527:Corneal Keratocytes / Q000187:drug effects / Q000502:physiology* / Q000637:transplantation*; D016039:Corneal Transplantation / Q000295:instrumentation; D004305:Dose-Response Relationship, Drug; D019544:Equipment Failure Analysis; D005260:Female; D006801:Humans; D007641:Keratolytic Agents / Q000008:administration & dosage; D008297:Male; D008875:Middle Aged; D011474:Prosthesis Design; D023822:Tissue Engineering / Q000295:instrumentation*; D054457:Tissue Scaffolds; D014212:Tretinoin / Q000008:administration & dosage*
D007641:Keratolytic Agents; D014212:Tretinoin
3D model; Cornea; collagen gel; in vitro; keratocytes; retinoic acid; tissue engineering